Eribulin mesylate: a promising new antineoplastic agent for locally advanced or metastatic breast cancer

ISSN： 1479-6694

Source： Future Oncology, Vol.7, Iss.3, 2011-03, pp. : 355-364

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A case of skeletal and bone marrow metastases from breast cancer treated with eribulin mesylate

By Pashaj Etleva Cortesi Laura Proietto Manuela Bonacorsi Goretta Liardo Eliana Federico Massimo

Future Oncology, Vol. 9, Iss. 10, 2013-10 ,pp. : 1437-1442

Future Medicine

Access to resources Recommend Favorite

Hyperthermia for locally advanced breast cancer

By Zagar Timothy M. Oleson James R. Vujaskovic Zeljko Dewhirst Mark W. Craciunescu Oana I. Blackwell Kimberly L. Prosnitz Leonard R. Jones Ellen L.

International Journal of Hyperthermia, Vol. 26, Iss. 7, 2010-10 ,pp. : 618-624

Informa Healthcare

Access to resources Recommend Favorite

A Cancer Research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifen

By Johnston S. Gumbrell L. Evans T. Coleman R. Smith I. Twelves C. Soukop M. Rea D. Earl H. Howell A. Jones A. Canney P. Powles T. Haynes B. Nutley B. Grimshaw R. Jarman M. Halbert G. Brampton M. Haviland J. Dowsett M. Coombes R.

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 4, 2004-04 ,pp. : 341-348

Springer Publishing Company

Access to resources Recommend Favorite

Locally Advanced Non-metastatic Breast Cancer: Analysis of Prognostic Factors in 125 Patients Homogeneously Treated with a Combined Modality Approach

By Gardin G. Rosso R. Campora E. Repetto L. Naso C. Canavese G. Catturich A. Corvo R. Guenzi M. Pronzato P. Baldini E. Conte P.F.

European Journal of Cancer, Vol. 31, Iss. 9, 1995-09 ,pp. : 1428-1433

Elsevier

Access to resources Recommend Favorite

A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancer

By Gartner Elaina Silverman Paula Simon Michael Flaherty Lawrence Abrams Judith Ivy Percy LoRusso Patricia

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 933-937

Springer Publishing Company

Access to resources Recommend Favorite